期 |
标题 |
文件 |
卷 1, 编号 1 (2021) |
Late Electrode Sepsis: Clinical Features, Diagnostics and Management. Clinical Cases |
(Rus)
(Eng)
|
Zimina V., Airapetian G., Grishkin Y., Sayganov S.
|
卷 1, 编号 1 (2021) |
Clinical Experience of Use of Sacubitril/Valsartan in a Patient with Dilated Cardiomyopathy, Chronic Heart Failure with Reduced Ejection Fraction and Ventricular Arrhythmias |
(Eng)
|
Snezhitskiy V., Kalatsei L., Matyukevich M., Grib S., Snezhickaya E., Madekina G., Epifanova Z., Chernaya E.
|
卷 1, 编号 1 (2021) |
The Role of Hyperuricemia in the Development of Atrial Fibrillation |
(Eng)
|
Barysenka T., Snezhitskiy V.
|
卷 1, 编号 1 (2021) |
Nuances of Cardiac Resynchronization Therapy in Patients with Dilated Cardiomyopathy and Atrial Fibrillation (a Clinical Case) |
(Rus)
(Eng)
|
Bitakova F., Gumerova V., Zbyshevskaya E., Zimina V., Novikova T., Ratmanov R., Saiganov S., Shcherbakova V.
|
卷 1, 编号 1 (2021) |
Postabaltive Pericarditis in Patient with a Prior History of Rheumatic Disease: a Case Report |
(Eng)
|
Zhelyakov E., Ardashev A., Kocharian A., Ginsburg M., Daniels E.
|
卷 1, 编号 1 (2021) |
Application of Hemostatic Agent “Haemoblock” for Pocket Hematoma Reduction. Design of the PEGAS study: a Multicenter Clinical Trial |
(Rus)
(Eng)
|
Nechepurenko A., Ilov N., Durmanov S., Shugaev P., Ivanchenko A., Suchkov I., Bsharat K., Lukin A., Medyanсeva L., Povarov V.
|
卷 2, 编号 1 (2022) |
Corrigendum to "Late Electrode Sepsis: Clinical Features, Diagnostics and Management. Clinical Cases". DOI: 10.17816/cardar71367 |
(Eng)
|
Zimina V., Airapetian G., Grishkin Y., Sayganov S.
|
卷 2, 编号 1 (2022) |
Disease-Modifying Therapy of Chronic Heart Failure on the Background of Heart Rhythm and Conductivity Disorders (Clinical Case) |
(Eng)
(Rus)
|
Novikova T., Novikov V., Bitakova F., Saiganov S., Shcherbakova V.
|
卷 2, 编号 1 (2022) |
Access Site Complications by Intracardiac Interventions |
(Eng)
(Rus)
|
Kimkov A.
|
卷 2, 编号 1 (2022) |
Factors of Cardiovascular Risk in Drivers of Locomotive Crews of Railway Transport with Ventricular Arrhythmias |
(Eng)
(Rus)
|
Metso K., Nikiforov V.
|
卷 2, 编号 1 (2022) |
Non-Invasive Electrophysiological Markers Associated With Long QT Syndrome |
(Eng)
|
Ardashev A., Snezhitskiy V., Kalatsei L.
|
卷 2, 编号 1 (2022) |
Catheter ablation of sustained idiopathic right ventricular outflow tract tachycardia in a pregnant patient without fluoroscopy |
(Eng)
|
Govorova Y., Pershina E., Tyukov P., Alekhnovich A., Lischuk A., Gromyko G.
|
卷 2, 编号 2 (2022) |
Epicardial Adipose Tissue and Cardiac Arrhythmias |
(Eng)
|
Kanorskii S.
|
卷 2, 编号 2 (2022) |
A Case of Mitral Annular Disjunction Combined with Ventricular Arrhythmias |
(Eng)
|
Novikova T., Basova V., Evdokimova L., Gnevasheva N., Itskovich I., Novikov V., Saiganov S., Shcherbakova V.
|
卷 2, 编号 2 (2022) |
Correction of Potentially Modifiable Components of Metabolic Syndrome for the Primary Prevention of Atrial Fibrillation in Comorbid Patients with Premature Atrial Complexes |
(Eng)
|
Olesin A., Konstantinova I., Ivanov V.
|
卷 2, 编号 2 (2022) |
Preoperative Prediction of Optimal Method and Site of Left Ventricular Electrode Implantation |
(Eng)
|
Stepanova V., Marinin V., Zubarev S.
|
卷 2, 编号 2 (2022) |
Endocardial Electrophysiological Study in Clinical Practice in Patients with Bradysystole and Conduction Rhythm Disorders: a review |
(Eng)
|
Zhelyakov E., Ardashev A.
|
卷 3, 编号 1 (2023) |
Diagnostic Value of Slow Conduction Index in Differential Diagnosis of Wide QRS Complex Arrhythmias with Left Bundle Branch Block Morphology |
(Eng)
(Rus)
|
Chmelevsky M., Budanova M., Stepanov D., Zhabina E., Tulintseva T.
|
卷 3, 编号 1 (2023) |
Atrial Fibrillation Recurrence Rate in Different Clinical Groups: Coronary Artery Disease and Age Matter |
(Eng)
(Rus)
|
Gorev M., Urazovskaya I.
|
卷 3, 编号 1 (2023) |
Long QT Syndrome in Young Athletes |
(Eng)
(Rus)
|
Chuprova S.Н., Melnikova I.
|
卷 2, 编号 4 (2022) |
Significance of the N-terminal Fragment of Brain Natriuretic Peptides in Predicting Ventricular Arrhythmias in Young and Middle-Aged Patients with Diabetes and Myocardial Infarction |
(Eng)
(Rus)
|
Wang Z., Makeeva T., Zbyshevskaya E., Butaev T., Saiganov S.
|
卷 2, 编号 4 (2022) |
Remodeling of the Left Atrium and the Possibility of Predicting Recurrences of Atrial Fibrillation in Various Variants of Sinus Rhythm Restoration |
(Eng)
(Rus)
|
Gromyko T., Saiganov S.
|
卷 2, 编号 4 (2022) |
Antitachycardic Therapy of ICD in Patients with Multiple Morphologies of Monomorphous Ventricular Tachycardia Refractory to Therapy |
(Eng)
(Rus)
|
Goncharik D., Barsukevich V., Plashchinskaya L., Zakhareuski M.
|
卷 3, 编号 2 (2023) |
Recurrence of Arrhythmias after Thoracoscopic MAZE procedure |
(Eng)
(Rus)
|
Lyashenko V., Ivanchenko A., Postol A., Azizov S., Vygovsky A., Schneider Y.
|
卷 3, 编号 2 (2023) |
Features of the use of oral anticoagulants in clinical practice: focus on gastrointestinal complications |
(Eng)
(Rus)
|
Bakulina N., Tikhonov S., Apresyan A., Ilyashevich I.
|
卷 3, 编号 2 (2023) |
Atrial fibrillation in patients with chronic kidney disease: features of pathogenesis and treatment |
(Eng)
(Rus)
|
Bakulina N., Scherbakov M., Anikonova L.
|
卷 3, 编号 3 (2023) |
Analysis of the endocardial stage of treatment of tachyarhythmias after open interventions for atrial fibrillation. Experience of one center |
(Eng)
(Rus)
|
Postol A., Antipov G., Ivanchenko A., Lyashenko V., Kalinin D., Kotov S., Vygovsky A., Shneider Y.
|
卷 3, 编号 3 (2023) |
Atrial fibrillation in a patient with diffuse myocardial fibrosis and mitral annular disjunction |
(Eng)
(Rus)
|
Evdokimova L., Itskovich I., Novikova T., Garpinchenko T.
|
卷 3, 编号 3 (2023) |
Clinical and genetic characterization of patients with catecholaminergic polymorphic ventricular tachycardia: a case series |
(Eng)
(Rus)
|
Komissarova S., Rineiska N., Chakova N., Niyazova S., Plashchinskaya L., Barsukevich V., Podpalova O.
|
卷 3, 编号 3 (2023) |
European guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 2022: cardiomyopathy. What’s new? |
(Eng)
(Rus)
|
Novikova T., Bitakova F., Ignateva V., Novikov V., Sayganov S., Shcherbakova V.
|
卷 3, 编号 4 (2023) |
Brugada syndrome: variability of clinical and genetic characteristics |
(Rus)
(Eng)
|
Komissarova S., Chakova N., Rineiska N., Niyazova S., Dolmatovich T., Barsukevich V., Plashchinskaya L.
|
卷 3, 编号 4 (2023) |
How to improve long-term results of patients with atrial fibrillation of non-valvular ethiology after embolism to main arteries of the limbs |
(Rus)
(Eng)
|
Sotnikov A., Mel’nikov M., Pyshnyy M., Semenyuta V.
|
卷 3, 编号 4 (2023) |
Frequency and features of cardiovascular diseases in spondyloarthritis |
(Rus)
(Eng)
|
Samigullina R., Mazurov V., Vasilenko E., Trofimov E.
|
卷 3, 编号 4 (2023) |
Cardiac Implantable Electronic Device Induced Tricuspid Regurgitation: A Mini Review |
(Eng)
|
Amanda R., Purwowiyoto S.
|
卷 2, 编号 3 (2022) |
2022 Esc Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: What is New? |
(Eng)
(Rus)
|
Novikova T., Novikov V., Sayganov S., Shcherbakova V.
|
卷 3, 编号 1 (2023) |
SLC2A9 Genotype Distribution and Left Atrium Diameter in Patients with Arterial Hypertension and Atrial Fibrillation |
(Eng)
(Rus)
|
Snezhitskiy V., Kopytsky A., Barysenko T.
|
卷 2, 编号 3 (2022) |
Differential Diagnostics of Wide QRS Complex Arrhythmias with Left Bundle Branch Block Morphology Using Slow Conduction Index |
(Eng)
(Rus)
|
Chmelevsky M., Budanova M., Treshkur T.
|
卷 2, 编号 3 (2022) |
Factors Associated with a Positive Hemodynamic Response to Cardiac Resynchronization Therapy |
(Eng)
(Rus)
|
Nechepurenko A., Ilov N., Zorin D., Romantcov E., Palnikova O.
|
卷 2, 编号 3 (2022) |
Incidence of Coronary Embolism in Group of Patients with Atrial Fibrillation and Myocardial Infarction |
(Eng)
(Rus)
|
Soloveva M., Boldueva S.
|
卷 2, 编号 3 (2022) |
Max Solomonovich Kushakovsky. Life and work |
(Eng)
(Rus)
|
Grishkin Y.
|
卷 3, 编号 2 (2023) |
New-onset atrial fibrillation in patients with SARS-CoV-2 pneumonia as a manifestation of acute myocardial injury |
(Eng)
(Rus)
|
Makeeva T., Zbyshevskaya E., Mayer M., Talibov F., Saiganov S.
|
卷 2, 编号 4 (2022) |
Prognostic value of N-terminal Brain Natriuretic Peptide (NT-proBNP) in Risk Assessment of Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Heart Failure with Reduced Left Ventricular Systolic Function |
(Eng)
(Rus)
|
Matsiukevich M., Bubeshka D., Snezhitskiy V.
|
卷 2, 编号 3 (2022) |
Editorial note |
(Eng)
(Rus)
|
Sayganov S.
|
1 - 43 的 43 信息 |
|